Baylor College of Medicine: Method Improves Detection of Potential Therapeutic Tumor Targets in Human Biopsies
January 17, 2024
January 17, 2024
HOUSTON, Texas, Jan. 17 (TNSres) -- The Baylor College of Medicine issued the following news:
Many cancers, including some types of breast cancer, are driven by alterations in the activity of cellular enzymes called kinases. Therapies that directly inhibit these cancer-promoting activities have proven to be effective for patients in which individual driving kinases can be diagnosed.
One major challenge to this therapeutic approach is to accurately quantify tumor kinases . . .
Many cancers, including some types of breast cancer, are driven by alterations in the activity of cellular enzymes called kinases. Therapies that directly inhibit these cancer-promoting activities have proven to be effective for patients in which individual driving kinases can be diagnosed.
One major challenge to this therapeutic approach is to accurately quantify tumor kinases . . .